Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Europe Cardiac Monitoring Market is expected to register a CAGR of 4.5% during the forecast period of 2018–2023. Cardiac monitoring devices are used to monitor and diagnose various abnormalities or disorders of the heart and the overall cardiovascular system.
Rise in Incidences of Cardiovascular Diseases
Cardiovascular disease (CVD) causes more than half of all the deaths across the European region. In Europe, CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis, and malaria combined. The rate of diagnosis of cardiovascular diseases is increasing over time due to high incidence rate of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. Hence, rise in the incidence of cardiovascular diseases drives the market. The other factors, such as investments in R&D of heart disease detection, ease of use and portability in devices, and the demand for home-based, point of care and remote monitoring cardiac systems are the major drivers for the market.
Risk of Infection from Implantable Monitoring Devices
Cardiac monitoring device is used by patients who require continuous monitoring of the heart for better treatment. Monitoring the cardiac output is a common practice in patients who undergo surgeries, as they will be under anesthesia and critical care. Cardiac implantable devices are used for related cardiac surgeries to monitor heart rate continuously. The patients who undergo any invasive procedures are at a risk of infection. The rising rate of infections due to these devices has tremendous economic implications on hospitals. Patients who are implanted with these monitoring devices are likely to require prolonged hospital stays, and the related costs rack up quickly. However, minimally invasive cardiac output monitors for clinical practice have been introduced into the market, which do not require the insertion of pacemaker. These devices utilize different techniques to monitor, and each has their own sources of potential errors and degree of invasiveness. Hence, the risk of infection due to implantable medical devices is a constraint for the market. The other factors, such as the low level of accuracy with invasive cardiac output monitoring devices and the stringent FDA and validator regulations are the major restraints for the cardiac monitoring market.
Germany Leads the Market in Europe
In 2017, Germany held the largest share in the cardiac monitoring market in Europe due to the large patient pool and wide acceptance of the advanced technology.
Key Developments in the Market
• September 2017: ABBOTT Confirm Insertable Cardiac Monitor (ICM) is the world's first and only smartphone compatible ICM, which got FDA clearance.
• July 2017: GE Healthcare collaborated with Heartflow technologies to provide better care of coronary artery patients.
The major players: CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, MEDTRONIC PLC, MENNEN MEDICAL, PHILLIPS HEALTHCARE, SIEMENS AG, ROCHE DIAGNOSTICS, CANON MEDICAL SYSTEMS CORPORATION, AND WELCH ALLYN, among others.
Reasons to Purchase the Report
• Current and future Europe cardiac monitoring market outlook in the developed and emerging markets.
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• The segment that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Rise in Incidences of Cardiovascular Diseases
Cardiovascular disease (CVD) causes more than half of all the deaths across the European region. In Europe, CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis, and malaria combined. The rate of diagnosis of cardiovascular diseases is increasing over time due to high incidence rate of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. Hence, rise in the incidence of cardiovascular diseases drives the market. The other factors, such as investments in R&D of heart disease detection, ease of use and portability in devices, and the demand for home-based, point of care and remote monitoring cardiac systems are the major drivers for the market.
Risk of Infection from Implantable Monitoring Devices
Cardiac monitoring device is used by patients who require continuous monitoring of the heart for better treatment. Monitoring the cardiac output is a common practice in patients who undergo surgeries, as they will be under anesthesia and critical care. Cardiac implantable devices are used for related cardiac surgeries to monitor heart rate continuously. The patients who undergo any invasive procedures are at a risk of infection. The rising rate of infections due to these devices has tremendous economic implications on hospitals. Patients who are implanted with these monitoring devices are likely to require prolonged hospital stays, and the related costs rack up quickly. However, minimally invasive cardiac output monitors for clinical practice have been introduced into the market, which do not require the insertion of pacemaker. These devices utilize different techniques to monitor, and each has their own sources of potential errors and degree of invasiveness. Hence, the risk of infection due to implantable medical devices is a constraint for the market. The other factors, such as the low level of accuracy with invasive cardiac output monitoring devices and the stringent FDA and validator regulations are the major restraints for the cardiac monitoring market.
Germany Leads the Market in Europe
In 2017, Germany held the largest share in the cardiac monitoring market in Europe due to the large patient pool and wide acceptance of the advanced technology.
Key Developments in the Market
• September 2017: ABBOTT Confirm Insertable Cardiac Monitor (ICM) is the world's first and only smartphone compatible ICM, which got FDA clearance.
• July 2017: GE Healthcare collaborated with Heartflow technologies to provide better care of coronary artery patients.
The major players: CARDIAC SCIENCE CORPORATION, GE HEALTHCARE, MEDTRONIC PLC, MENNEN MEDICAL, PHILLIPS HEALTHCARE, SIEMENS AG, ROCHE DIAGNOSTICS, CANON MEDICAL SYSTEMS CORPORATION, AND WELCH ALLYN, among others.
Reasons to Purchase the Report
• Current and future Europe cardiac monitoring market outlook in the developed and emerging markets.
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• The segment that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
